At 18.5x earnings and 12.6x forward earnings, the market is pricing ACM as a moderate-growth industrial rather than a cyclical value trap, and the 1.1 forward PEG suggests the valuation is roughly aligned with expected growth rather than euphoric. However, the Altman Z-Score of 2.2 places the company in a gray zone where balance sheet strength cannot be taken for granted, especially in a capital-intensive industry. With a Market Cap of $10,807M and a Price/Sales of 0.7, investors are not paying a premium on revenue, but the spread between current EPS of 10.1 and next year’s estimated $4.55 raises serious earnings durability questions. This is not a distressed multiple, but it is not a fortress either—the stock looks fairly valued to modestly discounted, contingent on execution and balance sheet discipline.